ヒストンの変種であるマクロH2Aは,CDK8の調節を通じてメラノーマの進行を抑制する
Avnish Kapoor1, Matthew S Goldberg, Lara K Cumberland
1Department of Oncological Sciences, Mount Sinai School of Medicine, 1425 Madison Avenue, New York, New York 10029, USA.
Nature
|December 24, 2010
まとめ
ヒストンの変種であるマクロH2A (mH2A) は悪性メラノーマの進行を抑制する. mH2Aの減少は,CDK8.8を上調することによって,メラノーマの悪性腫瘍,増殖,転移の増加と相関する.
科学分野:
- エピジェネティクス エピジェネティクス
- がん生物学 がん生物学
- クロマチンの生物学
背景:
- 癌には,染色体変化を含む遺伝的および表遺伝的変異が含まれます.
- 癌の発症と進行におけるヒストン変異の役割は,完全に理解されていません.
- マクロH2A (mH2A) のようなヒストンの変異は,核細胞の機能とクロマチンの性質を変化させます.
研究 の 目的:
- 悪性メラノーマの進行におけるヒストン変種マクロH2A (mH2A) の役割を調査する.
- mH2A発現とメラノーマの悪性との相関を判定する.
- mH2Aがメラノーマ発症に影響を与える分子メカニズムを解明する.
主な方法:
- メラノーマの細胞系と患者の組織におけるmH2Aアイソフォーム発現を分析した.
- メラノーマ細胞におけるmH2Aのノックダウンと復元実験を行う.
- 細胞の増殖,移動,成長,転移に対するmH2Aの効果を in vitroおよびin vivoで調査する.
- mH2A媒介のメラノーマ進行におけるCDK8の役割を評価する.
主要な成果:
- mH2Aイソフォームの喪失は,メラノーマ細胞の悪性腫瘍の増加と正に相関しています.
- 低悪性メラノーマ細胞のmH2Aノックダウンにより,増殖,移住,成長,転移が増加しました.
- mH2Aの発現を回復することで,これらの悪性現象型が逆転した.
- mH2Aの損失は,部分的にCDK8.8の転写上調節によって腫瘍の進行を促進します.
- CDK8抑制はメラノーマ細胞の増殖を抑制し,CDK8のノックダウンはmH2A損失による増殖の利点を相殺した.
- メラノーマ患者のサンプルで,mH2AとCDK8発現の間の有意な逆相関が観察されました.
結論:
- マクロH2A (mH2A) は,悪性メラノーマの進行を抑制する作用をします.
- mH2Aの損失は,CDK8のアップレギュレーションを通じてメラノーマ発症と転移に寄与する.
- mH2Aは,悪性メラノーマの進行を抑制する重要なクロマチンの成分です.
さらに関連する動画
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
関連する概念動画
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...